Clinical trials and tribulations

EMBO Rep. 2024 Apr;25(4):1690-1691. doi: 10.1038/s44319-024-00079-9. Epub 2024 Feb 5.

Author

Affiliation

¹ QIMR Berghofer Medical Research Institute in Brisbane, Brisbane, QLD, Australia. FGannon@qimrberghofer.edu.au.

Abstract

We need better post-approval monitoring and reporting to assess the efficiency of new cancer therapies in the real world beyond clinical trials.

Publication types

Review